𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New aspects of the inflammatory process in systemic lupus erythematosis

✍ Scribed by M. Rister; D. Mitrenga; A. Schneider


Publisher
SP Birkhäuser Verlag Basel
Year
1984
Tongue
English
Weight
182 KB
Volume
15
Category
Article
ISSN
1420-908X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Anti–lipoprotein lipase antibodies: A ne
✍ Jozélio Freire de Carvalho; Eduardo Ferreira Borba; Vilma Santos Trindade Viana; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

## Abstract ## Objective The novel description of antibodies to lipoprotein lipase (anti‐LPL) associated with dyslipoproteinemia prompted us to analyze the association of anti‐LPL with clinical and serologic features in patients with systemic lupus erythematosus (SLE) and its link to markers of in

Estrogen metabolism in the (New Zealand
✍ Alan N. Baer; Floyd A. Green 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

Hepatic microsomal estrogen metabolism was analyzed in the (New Zealand black x New Zealand white)F, ([NZB X NZWIF,) murine model of systemic lupus erythematosus. Both the estrogen 2-hydroxylase activity (per mg microsomal protein) and the hepatic cytochrome P-450 content were higher in premorbid (N

Some new aspects in the conformational a
✍ Elisabeth Langer; Harald Lehner 📂 Article 📅 1974 🏛 Elsevier Science 🌐 French ⚖ 183 KB

In recent years many data have been accumulated demonstrating that the strain in polycyclic ring systems (originating either from non bonded interactions of substituents or from a change in hybridisation at one site of the molecule) 1 may be relieved by alteration of bond angles . In turn this leads

Two aspects of the clinical and humanist
✍ Campbell, Robert ;Cooper, Glinda S. ;Gilkeson, Gary S. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## Objective To evaluate mortality risk and predictors among recently diagnosed systemic lupus erythematosus (SLE) patients. ## Methods The vital status of 265 SLE patients and 355 controls enrolled in the Carolina Lupus Study (median time since diagnosis 13 months) was determined ∼5